| dc.creator | Costa V.P. | |
| dc.creator | Da Silva R.S. | |
| dc.creator | Renato Jr. A. | |
| dc.date | 2013 | |
| dc.date | 2015-06-25T19:15:06Z | |
| dc.date | 2015-11-26T15:12:46Z | |
| dc.date | 2015-06-25T19:15:06Z | |
| dc.date | 2015-11-26T15:12:46Z | |
| dc.date.accessioned | 2018-03-28T22:22:51Z | |
| dc.date.available | 2018-03-28T22:22:51Z | |
| dc.identifier | | |
| dc.identifier | Arquivos Brasileiros De Oftalmologia. , v. 76, n. 1, p. 6 - 9, 2013. | |
| dc.identifier | 42749 | |
| dc.identifier | 10.1590/S0004-27492013000100003 | |
| dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-84880433520&partnerID=40&md5=d7d8972f2f0622d2545ae302245f9d4d | |
| dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/89201 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/89201 | |
| dc.identifier | 2-s2.0-84880433520 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1258460 | |
| dc.description | Purpose: To evaluate the need for artificial tears by glaucoma patients undertopical hypotensive treatment and to identify risk factors associated with it. Methods: The charts of 175 glaucoma patients under medical treatment and 175age-matched controls were reviewed. Age, gender, use of artificial tears, number of glaucoma medications used, and duration of treatment were recorded. Results: Significantly more glaucoma patients (n=92; 52.6%) used artificial tearscompared to age-matched controls (n=31; 17.7%) (p<0.001). Significantly morefemales (n=81; 39%) than males (n=42; 28.9%) used artificial tears (p=0.036). Whenthe whole population was analyzed, female gender (OR=1.63) and the presenceof glaucoma (OR= 5.14) were risk factors for the use of artificial tears (p<0.05).When the glaucoma population was analyzed, female gender (OR=2.57), numberof medications >2 (OR=1.92), and duration of treatment >5 years (OR=2.93) wererisk factors for the use of artificial tears (p<0.05).Conclusions: Topical treatment with antiglaucoma medication is a risk factor forthe use of artificial tears. Female gender and long-term treatment of glaucoma with two or more medications were aggravating factors for the need for artificial tears. | |
| dc.description | 76 | |
| dc.description | 1 | |
| dc.description | 6 | |
| dc.description | 9 | |
| dc.description | Fechtner, R.D., Godfrey, D.G., Budenz, D., Stewart, J.A., Stewart, W.C., Jasek, M.C., Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications (2010) Cornea, 29 (6), pp. 618-621 | |
| dc.description | Leung, E.W., Medeiros, F.A., Weinreb, R.N., Prevalence of ocular surface disease in glaucoma patients (2008) J Glaucoma, 17 (5), pp. 350-355 | |
| dc.description | Baudouin, C., Labbe, A., Liang, H., Pauly, A., Brignole-Baudouin, F., Preservatives in eyedrops: the good, the bad and the ugly (2010) Prog Retin Eye Res [Internet], 29 (4), pp. 312-334. , http://www.sciencedirect.com/science/article/pii/S1350946210000157, [cited 2012 Jun 12] | |
| dc.description | Pisella, P.J., Fillacier, K., Elena, P.P., Debbasch, C., Baudouin, C., Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits (2000) Ophthalmic Res [Internet], 32 (1), pp. 3-8. , http://www.karger.com/Article/FullText/55579, [cited 2012 Mar 10] | |
| dc.description | Schiffman, R.M., Christianson, M.D., Jacobsen, G., Hirsch, J.D., Reis, B.L., Reliability and validity of the Ocular Surface Disease Index (2000) Arch Ophthalmol [Internet], 118 (5), pp. 615-621. , http://archopht.jamanetwork.com/article.aspx?articleid=413145, [cited 2010 Nov 21] Comment in: Arch Ophthalmol. 2001;119(3):456 | |
| dc.description | (2007), 5 (2), pp. 75-92. , The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul SurfDe Tavares, F.P., Fernandes, R.S., Bernardes, T.F., Bonfioli, A.A., Soares, E.J., Dry eye disease (2010) Semin Ophthalmol, 25 (3), pp. 84-93 | |
| dc.description | do Baffa, L.P., Ricardo, J.R., Dias, A.C., Módulo, C.M., Braz, A.M., Paula, J.S., Tear film and ocular surface alterations in chronic users of antiglaucoma medications (2008) Arq Bras Oftalmol [Internet], 71, pp. 18-21. , http://www.scielo.br/pdf/abo/v71n1/v71n1a04.pdf, cited 2010 Oct 21 | |
| dc.description | Garcia-Catalan, M.R., Jerez-Olivera, E., Benitez-Del-Castillo-Sanchez, J.M., [Dry eye and quality of life] (2009) Arch Soc Esp Oftalmol [Internet], 84 (9), pp. 451-458. , http://www.oftalmo.com/seo/archivos/maquetas/F/350415A1-04F3-FF09-73C4-000049E3D6EF/articulo.pdf, [cited 2010 Jun 21] | |
| dc.description | Spanish | |
| dc.description | Rosenberg, E.S., Asbell, P.A., Essential fatty acids in the treatment of dry eye (2010) Ocul Surf, 8 (1), pp. 18-28 | |
| dc.description | Ervin, A.M., Wojciechowski, R., Schein, O., Punctal occlusion for dry eye syndrome (2010) Cochrane Database Syst Rev [Internet], 8 (9). , http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006775.pub2/full, [cited 2011 Aug 25];:CD006775 | |
| dc.description | Donnenfeld, E., Pflugfelder, S.C., Topical ophthalmic cyclosporine: pharmacology and clinical uses (2009) Surv Ophthalmol [internet], 54 (3), pp. 321-338. , http://www.sciencedirect.com/science/article/pii/S003962570900037, [cited 2012 Jun 21] | |
| dc.description | Comment in: Surv Ophthalmol.2010;55(2):189 | |
| dc.description | Abelson, M.B., Ousler, G.W., Maffei, C., Dry eye in 2008 (2009) Curr Opin Ophthalmol, 20 (4), pp. 282-286 | |
| dc.description | Ambrosio Jr., R., Tervo, T., Wilson, S.E., LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment (2008) J Refract Surg, 24 (4), pp. 396-407 | |
| dc.description | Fonseca, E.C., Arruda, G.V., Rocha, E.M., [Dry eye: etiopathogenesis and treatment] (2010) Arq Bras Oftalmol [Internet], 73 (2), pp. 197-203. , http://www.scielo.br/pdf/abo/v73n2/v73n2a21.pdf, [cited 2012 Jun 21];Portuguese | |
| dc.description | Schmier, J.K., Covert, D.W., Characteristics of respondents with glaucoma and dry eye in a national panel survey (2009) Clin Ophthalmol [Internet], 3, pp. 645-650. , http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788591/, [cited 2010 Dec 21] | |
| dc.description | Martone, G., Frezzotti, P., Tosi, G.M., Traversi, C., Mittica, V., Malandrini, A., An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology (2009) Am J Ophthalmol, 147 (4), pp. 725-35. , e1 | |
| dc.description | Behrens, A., Doyle, J.J., Stern, L., Chuck, R.S., McDonnell, P.J., Azar, D.T., Dua, H.S., Yiu, S.C., Dysfunctional tear syndrome: a Delphi approach totreatment recommendations (2006) Cornea, 25 (8), pp. 900-907. , Dysfunctional tear syndrome study group, Comment in: Cornea. 2007 | |
| dc.description | 26(7):901 | |
| dc.description | Dogru, M., Stern, M.E., Smith, J.A., Foulks, G.N., Lemp, M.A., Tsubota, K., Changing trends in the definition and diagnosis of dry eyes (2005) Am J Ophthalmol, 140 (3), pp. 507-508 | |
| dc.description | Herrero-Vanrell, R., Peral, A., [International Dry Eye Workshop (DEWS). Update of the disease] (2007) Arch Soc Esp Oftalmol [Internet], 82 (12), pp. 733-734. , http://www.oftalmo.com/seo/archivos/maquetas/F/388144D4-E886-0149-62B8-00003843D50F/articulo.pdf, [cited 2009 Aug 21] | |
| dc.description | Spanish | |
| dc.description | Yenice, O., Temel, A., Orum, O., The effect of artificial tear administration on visual field testing in patients with glaucoma and dry eye (2007) Eye (Lond) [Internet], 21 (12), pp. 214-217. , http://www.nature.com/eye/journal/v21/n2/full/6702252a.html, [cited 2010 Nov 21] | |
| dc.description | Rossi, G.C., Tinelli, C., Pasinetti, G.M., Milano, G., Bianchi, P.E., Dry eye syndrome-related quality of life in glaucoma patients (2009) Eur J Ophthalmol, 19 (4), pp. 572-579 | |
| dc.description | Kuppens, E.V., van Best, J.A., Sterk, C.C., de Keizer, R.J., Decreased basal tear turnover in patients with untreated primary open-angle glaucoma (1995) Am J Ophthalmol, 120 (1), pp. 41-46 | |
| dc.description | Jaenen, N., Baudouin, C., Pouliquen, P., Manni, G., Figueiredo, A., Zeyen, T., Ocular symptoms and signs with preserved and preservative-free glaucoma medications (2007) Eur J Ophthalmol, 17 (3), pp. 341-349 | |
| dc.description | Uusitalo, H., Chen, E., Pfeiffer, N., Brignote-Baudouin, F., Kaamiranta, K., Leino, M., Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication (2010) Acta Ophthalmol [Internet], 88 (3), pp. 329-336. , http://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2010.01907.x/pdf, [cited 2012 Sep 15] | |
| dc.description | Ammar, D.A., Noecker, R.J., Kahook, M.Y., Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells (2010) Adv Ther [Internet], 27, pp. 837-845. , http://link.springer.com/article/10.1007%2Fs12325-010-0070-1, cited 2012 Oct 15 | |
| dc.language | en | |
| dc.publisher | | |
| dc.relation | Arquivos Brasileiros de Oftalmologia | |
| dc.rights | aberto | |
| dc.source | Scopus | |
| dc.title | The Need For Artificial Tears In Glaucoma Patients: A Comparative, Retrospective Study | |
| dc.type | Artículos de revistas | |
